Silo Pharma Shares Are Trading Higher After the Company Announced Its Submission of a Pre-Investigational New Drug Briefing Package and Meeting Request to the FDA for SPC-15 as a Treatment for PTSD and Anxiety.
Silo Pharma Shares Are Trading Higher After the Company Announced Its Submission of a Pre-Investigational New Drug Briefing Package and Meeting Request to the FDA for SPC-15 as a Treatment for PTSD and Anxiety.
Silo Pharma股票交易上漲，因為該公司宣佈已提交一份用於處理Spc-15治療創傷後壓力症候群和焦慮症的Investigational New Drug 預研報告和會議請求給美國食品藥品監督管理局。
Silo Pharma Shares Are Trading Higher After the Company Announced Its Submission of a Pre-Investigational New Drug Briefing Package and Meeting Request to the FDA for SPC-15 as a Treatment for PTSD and Anxiety.
Silo Pharma股票上漲了，因爲公司宣佈就SPC-15作爲治療創傷後應激障礙和焦慮的預臨床新藥提交前研究新藥簡報和會議請求給FDA。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。